Innate immune activation as a broad-spectrum biodefense strategy: prospects and research challenges
- PMID: 14564345
- PMCID: PMC7125525
- DOI: 10.1016/s0091-6749(03)02025-6
Innate immune activation as a broad-spectrum biodefense strategy: prospects and research challenges
Abstract
Biodefense strategies require protection against a broad and largely unforeseen spectrum of pathogens--the forte of innate immune system defenses--that have evolved over millennia to function within moments of encountering either ancient or newly emerging pathogens. Although constitutive, the innate immune system is activated by the presence of microbes or their products, providing a rationale for a potential biodefense strategy. Both prophylactic and postexposure strategies involving innate immune stimulation have been shown to be plausible to prevent or ameliorate infections in animal models. Innate immune-activating compounds based on conserved microbial components recognized by toll-like molecules and other receptors could be synthesized and delivered like drugs by using an entirely different strategy from conventional vaccination. However, important theoretic and practical questions emerge about developing and deploying innate immune protective strategies for biodefense. This rostrum discusses prospects and problems in the overall approach itself. Important topics include microbe-specific issues about innate immune system effectiveness against highly virulent pathogens and general questions, such as whether innate immune responses will be safe and effective if used in a diverse human population of different age groups and with different genetic makeups.
Figures

Comment in
-
Risks of smallpox vaccination: 200 years after Jenner.J Allergy Clin Immunol. 2003 Oct;112(4):683-5. doi: 10.1016/j.jaci.2003.07.002. J Allergy Clin Immunol. 2003. PMID: 14564344 Review. No abstract available.
References
-
- Nau GJ, Schlesinger A, Richmond JF, Young RA. Cumulative toll-like receptor activation in human macrophages treated with whole bacteria. J Immunol. 2003;170:5203–5209. - PubMed
-
- Cohen J. The immunopathogenesis of sepsis. Nature. 2002;420:885–891. - PubMed
-
- Ezekowitz RA. Mannose-binding lectin in prediction of susceptibility to infection. Lancet. 2001;358:598–599. - PubMed
-
- Klinman DM, Verthelyi D, Takeshita F, Ishii KJ. Immune recognition of foreign DNA: a cure for bioterrorism? Immunity. 1999;11:123–129. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical